Independent Family Office LLC Buys 155 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Independent Family Office LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 31.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 655 shares of the healthcare conglomerate’s stock after purchasing an additional 155 shares during the period. Independent Family Office LLC’s holdings in UnitedHealth Group were worth $385,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of UNH. Bank of New York Mellon Corp raised its position in shares of UnitedHealth Group by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after acquiring an additional 35,533 shares during the last quarter. International Assets Investment Management LLC increased its holdings in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Ameriprise Financial Inc. grew its stake in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after acquiring an additional 21,149 shares during the period. Finally, Fisher Asset Management LLC grew its stake in UnitedHealth Group by 3.5% in the third quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock valued at $1,869,320,000 after acquiring an additional 107,097 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $0.18 during mid-day trading on Tuesday, hitting $608.34. 291,908 shares of the stock were exchanged, compared to its average volume of 3,839,301. The firm has a fifty day moving average of $585.43 and a 200 day moving average of $556.65. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market cap of $559.84 billion, a PE ratio of 39.64, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the company posted $6.56 EPS. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

Several research firms recently commented on UNH. Stephens reduced their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday. Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Cantor Fitzgerald raised their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Finally, Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $621.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.